Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions

NCT: NCT07749170 · RECRUITING

NCT IDNCT07749170
StatusRECRUITING
Start Date2026-06-26
Completion2028-09
SponsorPenumbra Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to collect safety and effectiveness data on the Penumbra System reperfusion catheters in participants with isolated primary non-dominant and distal M2 occlusions who undergo endovascular mechanical thrombectomy (EVT). Additionally, this study aims to observe characteristics and outcomes of participants treated with medical management (MM) alone and those who receive EVT + MM per current medical practice.

Frequently Asked Questions

What is FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions?

FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions is a clinical trial registered under NCT07749170. Current status: RECRUITING.

What is the status of NCT07749170?

The current status of NCT07749170 (FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions) is: RECRUITING.

When did FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions start?

FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions started on 2026-06-26.

Related Devices

K152541Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc. K161064Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. K161640Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. K162901Penumbra 3D Revascularization DevicePenumbra, Inc. K173761Penumbra System Reperfusion Catheter JET 7Penumbra, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑